Literature DB >> 16430520

Capnocytophaga in the dental plaque of immunocompromised children with cancer.

J L Sixou1, A Aubry-Leuliette, O De Medeiros-Battista, S Lejeune, A Jolivet-Gougeon, H Solhi-Pinsard, V Gandemer, M Barbosa-Rogier, M Bonnaure-Mallet.   

Abstract

OBJECTIVES: (i) To compare the prevalence and levels of Capnocytophaga, a known systemic pathogen in immunocompromised patients, in the dental plaque of healthy children and children with cancer, and (ii) to determine the susceptibility of strains isolated from cancer patients to a range of antibiotics. PATIENTS AND METHODS: Thirty-one children with cancer undergoing a first course of immunosuppressive chemotherapy and 30 healthy control children were included in the study. Samples were collected on days 0, 7, 14, and 21 of the cure (and equivalent dates in controls). Susceptibility to antibiotics was tested using an agar dilution method and galleries with predefined concentrations of selected antibiotics.
RESULTS: There was a significant drop in the total anaerobic cultivable flora on day 14 and in the prevalence of Capnocytophaga on days 14 and 21 in the children with cancer. The proportion of Capnocytophaga in the anaerobic flora, however, was high in certain cancer patients. Beta-lactam/beta-lactamase inhibitor combinations, imipenem, clindamycin, and tetracycline were the most effective against Capnocytophaga.
CONCLUSION: This study showed that Capnocytophaga decreased in prevalence and proportion in the dental plaque of cancer patients during chemotherapy but became predominant in some cases. It is recommended that imipenem or beta-lactam/beta-lactamase inhibitor combinations be used to treat Capnocytophaga bacteraemia.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16430520     DOI: 10.1111/j.1365-263X.2006.00697.x

Source DB:  PubMed          Journal:  Int J Paediatr Dent        ISSN: 0960-7439            Impact factor:   3.455


  3 in total

Review 1.  Gastrointestinal and liver infections in children undergoing antineoplastic chemotherapy in the years 2000.

Authors:  Elio Castagnola; Eliana Ruberto; Alfredo Guarino
Journal:  World J Gastroenterol       Date:  2016-07-07       Impact factor: 5.742

2.  Alterations of the Subgingival Microbiota in Pediatric Crohn's Disease Studied Longitudinally in Discovery and Validation Cohorts.

Authors:  Judith Kelsen; Kyle Bittinger; Helen Pauly-Hubbard; Leah Posivak; Stephanie Grunberg; Robert Baldassano; James D Lewis; Gary D Wu; Frederic D Bushman
Journal:  Inflamm Bowel Dis       Date:  2015-12       Impact factor: 5.325

3.  Oral microbiota and cancer.

Authors:  Jukka H Meurman
Journal:  J Oral Microbiol       Date:  2010-08-10       Impact factor: 5.474

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.